T cell exhaustion has a major role in failure to control chronic infection. High expression of inhibitory receptors, including PD-1, and the inability to sustain functional T cell responses contribute to exhaustion. However, the transcriptional control of these processes remains unclear. Here we demonstrate that the transcription factor T-bet regulated the exhaustion of CD8 + T cells and the expression of inhibitory receptors. T-bet directly repressed transcription of the gene encoding PD-1 and resulted in lower expression of other inhibitory receptors. Although a greater abundance of T-bet promoted terminal differentiation after acute infection, high T-bet expression sustained exhausted CD8 + T cells and repressed the expression of inhibitory receptors during chronic viral infection. Persistent antigenic stimulation caused downregulation of T-bet, which resulted in more severe exhaustion of CD8 + T cells. Our observations suggest therapeutic opportunities involving higher T-bet expression during chronic infection.
CD8 + T cells have a crucial role in the eradication of many intracellular infections and can provide potent protective immunity. After acute infection or vaccination, antigen-specific effector CD8 + T cells acquire and maintain the potential to efficiently accomplish various functions, including cytokine production and cytotoxicity, as well as the ability to rapidly proliferate and expand in number after reexposure to antigen 1 . These memory CD8 + T cells are also maintained for long periods without antigen by interleukin 7 (IL-7) and IL-15 (ref. 1) . In contrast, during chronic infection, virus-specific CD8 + T cells become dysfunctional and fail to form optimal memory cells. These 'exhausted' CD8 + T cells require antigen for survival and no longer use IL-7 or IL-15 efficiently 2 . The loss of CD8 + T cell function during chronic viral infection is a stepwise process in which the ability to make IL-2, tumor necrosis factor, interferon-γ (IFN-γ) and β-chemokines is progressively lost as the cells become more exhausted 2 . Defects in proliferation, cytotoxicity and survival are also characteristics of exhausted CD8 + T cells 2 . In the most severe examples of exhaustion, which occur when viral or antigen load is high, virus-specific CD8 + T cells can be physically deleted 2 . Exhaustion of CD8 + T cells is observed in mice during chronic infection with lymphocytic choriomeningitis virus (LCMV) and other persistent viral infections, in primate models during infection with simian immunodeficiency virus and in humans during chronic viral infections, such as infection with human immunodeficiency virus, hepatitis C virus or hepatitis B virus, or in cancer 2 .
Inhibitory receptors at the cell surface have a major role in regulating T cell exhaustion during chronic infection. Expression of PD-1, an inhibitory receptor of the CD28-CTLA-4 family, is upregulated considerably, and its high expression is sustained during chronic LCMV infection in mice 3, 4 . Blocking the PD-1 signaling pathway in vivo reinvigorates exhausted CD8 + T cell responses, which leads to enhanced control of viral replication 3 . Those observations about LCMV infection in mouse models have also been confirmed for primate models and humans, as blockade of the PD-1 pathway enhances T cell responses specific for human immunodeficiency virus and hepatitis C virus in vitro and improves the outcome of infection with simian immunodeficiency virus in macaques by diminishing viral burden and prolonging survival 2 . Studies also suggest an important role for the PD-1 pathway in tumor immunity 5, 6 , and early clinical trials blocking the PD-1 pathway in patients with cancer have shown promise 7 .
In addition to upregulating PD-1, exhausted CD8 + T cells upregulate many other inhibitory receptors at the cell surface, including LAG-3, CD244, CD160, CTLA-4 and Tim- 3 (refs. 4,8,9) . These receptors act cooperatively in mediating CD8 + T cell dysfunction. Simultaneous blockade of PD-1 with LAG-3 or Tim-3 is much better at reversing CD8 + T cell dysfunction and diminishing viral burden than is blockade of each pathway alone during chronic infection in mice 8, 10 , and in vitro data from humans are consistent with these A r t i c l e s observations 11 . The underlying mechanisms that control the expression of these inhibitory pathways during chronic viral infection, however, remain poorly understood.
Comparison of gene expression in exhausted and effector or memory CD8 + T cells from mice has shown substantial changes in many pathways 4 . In addition to having altered expression of inhibitory receptors, exhausted CD8 + T cells have altered expression of transcription factors and genes encoding other molecules involved in transcriptional regulation. Expression of the transcriptional repressor Blimp-1 is especially high in exhausted CD8 + T cells 12 and promotes the expression of inhibitory receptors, including PD-1, LAG-3, CD160 and CD244. During acute infection, Blimp-1 promotes the terminal differentiation of effector CD8 + T cells toward the CD127 lo KLRG-1 hi subset instead of toward CD127 hi KLRG-1 lo memory precursor cells 13, 14 . Thus, Blimp-1 seems to repress the formation of memory CD8 + T cells and promote terminal differentiation during both acute and chronic viral infection.
Like high Blimp-1 expression, high expression of the transcription factor T-bet promotes the formation of terminally differentiated CD127 lo KLRG-1 hi effector CD8 + T cells, whereas the CD127 hi KLRG-1 lo memory precursors have lower expression of T-bet. Inflammation is an important factor that drives high T-bet expression and, therefore, terminal differentiation of T cells during acute infection 15 . In the absence of T-bet, effector CD8 + T cells are mostly CD127 hi KLRG-1 lo and become memory CD8 + T cells with enhanced recall responses 16 . Thus, in acute infection, T-bet and Blimp-1 have similar (and perhaps partially overlapping) roles in promoting the effector function and terminal differentiation of CD8 + T cells.
In this study, we examined the role of T-bet in regulating virusspecific CD8 + T cell responses during chronic viral infection. We identified a critical role for T-bet in CD8 + T cell exhaustion distinctly different from its role in acute infection. T-bet expression was downregulated in exhausted CD8 + T cells in response to persistent antigen, and expression of T-bet was inversely correlated with the expression of a subset of inhibitory receptors, including PD-1. Genetic ablation of T-bet exacerbated CD8 + T cell exhaustion and resulted in a higher viral load. Conversely, overexpression of T-bet improved the fitness of exhausted CD8 + T cells and resulted in lower expression of PD-1 and other inhibitory receptors. T-bet bound directly to a regulatory region upstream of the transcriptional start site of the gene encoding PD-1 (Pdcd1). Thus, during chronic viral infection, T-bet regulates CD8 + T cell exhaustion by sustaining CD8 + T cell responses and by repressing the expression of PD-1 and other inhibitory receptors.
RESULTS

T-bet expression in chronic and acute infection
To examine the role of T-bet in CD8 + T cells during chronic viral infection, we compared T-bet expression in mice infected with either the Armstrong strain of LCMV (Arm), which is cleared within 8-10 d of infection, or LCMV clone 13, which induces 2-3 months of viremia and persists long-term in some tissues. We transiently depleted one set of clone 13-infected mice of CD4 + T cells before infection, a treatment that exacerbates viral load and CD8 + T cell exhaustion 8 . All CD44 hi CD8 + T cells had higher T-bet expression than did CD44 lo CD8 + T cells (Supplementary Fig. 1 ). We did not detect T-bet staining in CD8 + T cells from T-bet-deficient mice (Supplementary Fig. 1 ). We assessed T-bet expression in CD8 + T cells positive for a tetramer of the LCMV glycoprotein epitope of amino acids 33-41 (gp33) in the context of H-2D b (called 'H-2D b gp33' here) and found T-bet expression was lower in such cells from clone 13-infected mice than in those from Arm-infected mice (Fig. 1a) . To determine whether this lower T-bet expression was due to a defect in initial induction, we examined T-bet expression in antigen-specific CD8 + T cells on days 1-3 after infection. For these experiments we used mice given adoptive transfer of CD8 + T cells from P14 mice in which all CD8 + T cells had transgenic expression of an H-2D b gp33-specific T cell antigen receptor (TCR). On days 1 and 3 after infection, T-bet expression was similar during infection with Arm or clone 13 ( Supplementary  Fig. 2 ), which suggested that there were no gross differences in the initial induction of T-bet in virus-specific CD8 + T cells. However, on day 8 after infection, cells from clone 13-infected mice had much lower expression of T-bet (Fig. 1b) . By day 16 after infection, two distinct subsets of T-bet-expressing tetramer-positive CD8 + T cells emerged during infection with clone 13: T-bet hi cells and T-bet lo cells (Fig. 1b) . The expression of T-bet in the T-bet hi group was similar to that observed during acute infection (Fig. 1b) . Notably, virus-specific CD8 + T cells in the mice depleted of CD4 + T cells were mainly T-bet lo . Thus, T-bet was induced in virus-specific CD8 + T cells during chronic LCMV infection, but persistence of infection corresponded with much lower T-bet expression in virus-specific CD8 + T cells than during acute infection. Fig. 3 ). There was no difference between wild-type and cHet mice in the frequency of antigen-specific CD8 + T cells in the spleen at day 8 after infection (Fig. 2a) . The frequency of antigen-specific CD8 + T cells in the spleens of cKO mice was lower than that of cHet or wild-type mice, which resulted in a slightly lower absolute number on day 8 after infection in some experiments (Fig. 2b) but not all experiments ( Supplementary Fig. 4) . Overall, the breadth and immunodominance of the responses were similar in wild-type and cKO mice at day 8 after infection ( Supplementary Fig. 4 ). In T-bet-deficient mice, memory CD8 + T cells are maintained long term after acute infection 16 . In contrast, by day 30 of infection with clone 13, there were many fewer antigen-specific cKO CD8 + T cells in the spleen (Fig. 2b ) and other tissues (Fig. 2c) . The cHet mice also had significantly fewer virus-specific CD8 + T cells in the bone marrow and blood at day 30 after infection with clone 13 (Fig. 2c) . A distinct population of CD44 hi CD8 + T cells was still present in cKO mice (Fig. 2a) , which suggested that the loss of LCMV-specific CD8 + T cells did not result from a more general defect in all CD8 + T cells.
T-bet is not required for the clearance of Arm 17 . However, during infection with clone 13, viremia was significantly greater in cKO mice than in wild-type mice, especially at later time points (Fig. 2d,e) . Ablation of a single copy of Tbx21 also resulted in a higher viral load, although this difference became significant only by ~2 months after infection (P < 0.05; Supplementary Fig. 5 ). These data suggest that T-bet has a role in sustaining the virus-specific CD8 + T cell response during chronic LCMV infection.
We next examined the ability of CD8 + T cells to make cytokines after antigen restimulation. Although antigen-specific cKO CD8 + T cells were able to degranulate, ~20% fewer cKO CD8 + T cells than virusspecific wild-type CD8+ T cells expressed granzyme B (data not shown). On day 8 after infection, the amount of the cytokines and chemokines produced per cell was similar for wild-type and T-bet deficient CD8 + T cells (Fig. 3a,b and data not shown). The percentage of cells producing both IFN-γ and the chemokine CCL3 (MIP-1α) was also similar for all groups (~75%; Fig. 3b ). T-bet can repress tumor necrosis factor, IL-2 and IL- 17 (refs. 16,17) . Indeed, cKO CD8 + T cells produced more IL-2, tumor necrosis factor and IL-17 on day 8 after infection than did wild-type CD8 + T cells (Supplementary Fig. 6 ). However, by day 30 after infection, fewer cKO CD8 + T cells than wild-type CD8 + T cells produced these cytokines after restimulation (Supplementary Fig. 6 ), which suggested that the lower abundance of virus-specific CD8 + T cells in cKO mice reflected loss of the cells rather than skewing toward an alternative lineage. Thus, T-bet seems to be needed to sustain a virusspecific CD8 + T cell response during chronic viral infection.
T-bet expression inversely correlates with PD-1 expression PD-1 has an important role in regulating T cell exhaustion and repressing effective T cell responses during chronic infection 2, 3 . There was more upregulation of PD-1 on virus-specific CD8 + T cells from clone 13-infected mice than on those from Arm-infected mice (Fig. 4) . An inverse correlation between T-bet and PD-1 was evident after day 8 after infection with clone 13 (for example, at day 26 after infection; Fig. 4b ). PD-1 int exhausted CD8 + T cells were predominantly T-bet hi , whereas nearly all PD-1 hi cells were T-bet lo . In clone 13-infected mice A r t i c l e s depleted of CD4 + T cells, virus-specific CD8 + T cells were mostly PD-1 hi and T-bet lo (Fig. 4b) . These results indicate that downregulation of T-bet is associated with higher PD-1 expression by exhausted CD8 + T cells. At day 30 after infection, virus-specific CD8 + T cells from cHet mice and the few remaining virus-specific CD8 + T cells in cKO mice were almost exclusively PD-1 hi , whereas wild-type cells included both PD-1 int and PD-1 hi subsets (Fig. 4c) . T-bet deficiency also resulted in higher PD-1 expression in virus-specific CD4 + T cells (Fig. 4c) . These results suggest that T-bet can influence PD-1 expression and that this relationship between the expression of T-bet and of PD-1 is not restricted to CD8 + T cells.
Persistent antigen drives T-bet downregulation
The loss of T-bet expression during chronic LCMV infection was somewhat paradoxical, as inflammation can increase T-bet expression 15 . On the basis of published in vitro studies 18 , we tested whether persistent TCR stimulation during chronic infection might have a negative effect on T-bet expression. The V35A variant of clone 13, which contains a point substitution in the immunodominant gp33 epitope 19 , causes chronic infection and, although it lacks the H-2D b gp33 epitope, induces T cell responses to all other CD8 + T cell epitopes 19 . We infected mice with wild-type clone 13 and, on day 8 after infection, adoptively transferred CD8 + T cells from those mice into congenic mice infected 8 d before with either wild-type or V35A clone 13 ( Fig. 5 and Supplementary Fig. 7a ). T-bet expression in H-2D b gp33-specific CD8 + T cells, which no longer received TCR stimulation, was significantly higher in hosts infected with V35A clone 13 than in those infected with wild-type clone 13 ( Fig. 5b) . We also studied CD8 + T cells specific for the LCMV glycoprotein epitope of amino acids 276-286 (gp276) in the context of H-2D b (H-2D b gp276), which were subjected to persistent TCR stimulation; we found that T-bet expression was not significantly higher and PD-1 expression was not significantly lower in such cells from hosts infected with wild-type clone 13 than in such cells from hosts infected with V35A clone 13 ( Fig. 5a,b) . T-bet was also more abundant in H-2D b gp33-specific CD8 + T cells than in H-2D b gp276-specific CD8 + T cells in recipients infected with V35A clone 13, whereas in mice infected with wild-type clone 13, T-bet expression was similar in these two populations. The failure of the H-2D b gp33-specific CD8 + T cells to downregulate T-bet in mice infected with the V35A variant virus indicated that persistent TCR stimulation was required for lower T-bet expression during chronic LCMV infection.
Cell-intrinsic regulation of PD-1 expression by T-bet
To determine whether T-bet has an intrinsic role in regulating PD-1, we used chimeric and adoptive-transfer strategies in which wild-type and T-bet deficient T cells were present in the same host and therefore were subjected to the same viral load, inflammation or changes in other cell types such as CD4 + T cells or dendritic cells ( Supplementary  Fig. 7b-e) . We established polyclonal mixed peripheral chimeras by adoptively transferring total CD8 + T cells from CD45.2 + cKO or cHet mice into CD45.1 + wild-type mice, followed by LCMV infection (Fig. 6a,b and Supplementary Fig. 7b,c) . On day 8 after infection, H-2D b gp33-and H-2D b gp276-specific cKO CD8 + T cells in clone 13-infected mice expressed significantly more PD-1 than did wildtype tetramer-positive CD8 + T cells in the same mice. A difference in PD-1 was also apparent after acute infection, although to a more modest extent (Fig. 6a) . Antigen-specific cKO CD8 + T cells were nearly undetectable in the chimeric mice at later time points, consistent with the results presented above (Fig. 2 and data not shown) . To examine the expression of inhibitory receptors over time, we generated cHet antigen-specific cells (below). *P < 0.05, **P < 0.005 and ***P < 0.001 (two-tailed unpaired Student's t-test). Data are representative of at least three independent experiments with at least four mice per group. chimeras, because cHet CD8 + T cells persisted longer than cKO CD8 + T cells did during chronic LCMV infection. On ~day 40 after infection, tetramer-positive cHet CD8 + T cells were exclusively PD-1 hi , whereas tetramer-positive wild-type CD8 + T cells in the same mice included both PD-1 hi and PD-1 int cells. These results suggest a cellintrinsic role for T-bet in regulating PD-1 expression.
To address the questions above in a setting in which potential differences in precursor frequency or TCR repertoire were not a factor, we transferred equal numbers of wild-type and Tbx21 +/− P14 CD8 + T cells into wild-type mice (T-bet-deficient P14 cells failed to persist long term in clone 13-infected mice (data now shown)), followed by LCMV infection (Supplementary Fig. 7d ). By day 40 after infection with clone 13, nearly all Tbx21 +/− P14 cells were PD-1 hi , whereas the wild-type P14 population in the same hosts included both PD-1 hi and PD-1 int cells (Fig. 6c) . PD-1 expression was also slightly higher in Tbx21 +/− P14 cells than in wild-type P14 cells even after Arm infection (Fig. 6c) . Together these experiments demonstrate a cell-intrinsic role for T-bet in regulating PD-1 expression in CD8 + T cells. The effect of T-bet on PD-1 expression was modest during acute infection but became greater during chronic infection.
Overexpressed T-bet sustains CD8 + responses in chronic infection
During acute infection, T-bet promotes the formation of short-lived, terminally differentiated CD8 + T cells 15 . To assess the effect of higher T-bet expression on CD8 + T cell responses during chronic infection, we retrovirally overexpressed T-bet in P14 CD8 + T cells ( Supplementary  Fig. 7e) . We then adoptively transferred T-bet-transduced P14 cells (marked by expression of green fluorescent protein (GFP); (Fig. 7b) . (Fig. 7c) , in agreement with published work 15 .
Consequently, GFP + T-bet-transduced P14 cells did not persist as well as the GFP + P14 cells transduced with empty vector did
During chronic infection, T-bet overexpression skewed GFP + P14 cells toward the PD-1 int subset (Fig. 7b) . T-bet overexpression also enhanced the persistence of P14 cells during chronic infection relative to the effect of the empty-vector control, and a greater percentage of GFP + T-betoverexpressing cells than GFP − cells was present, especially at later time points (beyond day 20 after infection; Fig. 7c ). These results suggested that higher T-bet expression resulted in less PD-1 and improved the persistence of exhausted CD8 + T cells during chronic infection. T-bet represses a set of inhibitory receptors Exhausted CD8 + T cells upregulate many inhibitory receptors, which act synergistically with PD-1 to promote exhaustion 4, 8, 11 . To determine whether T-bet also affects the expression of other inhibitory receptors, we next examined the expression of LAG-3, BTLA, CD160, KLRG-1, CD244 and Tim-3 on virus-specific CD8 + T cells from wildtype and cHet mice at day 40 after infection with clone 13 (Fig. 8a) . In cHet mice, exhausted tetramer-positive CD8 + T cells were mainly LAG-3 hi , CD160 hi and BTLA hi , which suggested that T-bet coordinately repressed these receptors during chronic LCMV infection. In contrast, KLRG-1 expression was lower in cHet mice, consistent with published studies demonstrating a positive role for T-bet in KLRG1 expression during acute infection 15 . The effect of T-bet on the expression of CD244 and Tim-3 was more complex, as PD-1 hi cells in cHet mice had heterogenous expression of these receptors. In addition, we observed changes in the expression of many other markers in T-bet-deficient antigen-specific CD8 + T cells during chronic infection (Supplementary Fig. 8 ).
Using the strategy described above of transferring wild-type plus Tbx21 +/− P14 cells together, we also found that the expression of LAG-3, CD160, and BTLA was higher on Tbx21 +/− P14 cells (Fig. 8b) . There was a slight shift toward higher CD244 expression, whereas Tim-3 expression was unchanged or slightly lower in Tbx21 +/− P14 cells. T-bet seemed to have a role in the early expression of Tim-3, as Tbx21 −/− P14 cells expressed less Tim-3 than did wild-type P14 cells at day 9 after infection with Arm or clone 13 ( Supplementary Fig. 9 ), consistent with a role for T-bet in the initial Tim-3 expression 20 . Higher T-bet expression achieved by the retroviral overexpression approach in P14 cells resulted in higher KLRG-1 expression (Fig. 8c) but repressed LAG-3, CD160 and BTLA, along with PD-1, during chronic LCMV infection. These results support the idea of a cellintrinsic role for T-bet in regulating the genes encoding many different inhibitory receptors and probably other genes in exhausted CD8 + T cells.
T-bet is a direct transcriptional repressor of PD-1
To address whether T-bet repressed Pdcd1 transcription directly, we used EL4 mouse lymphoma cells with constitutive PD-1 expression 21 but minimal expression of T-bet 22 (Fig. 9a,b) . Ectopic expression of T-bet in EL4 cells significantly downregulated PD-1 (Fig. 9b,c) .
To identify the regulatory elements of the Pdcd1 locus targeted by T-bet, we used a luciferase reporter construct containing two highly conserved regulatory regions (CR-B and CR-C) found in a fragment ~2,300 base pairs in length upstream of Pdcd1. CR-C is reported to contain a site for the transcription factor NFAT important for the transcriptional induction of Pdcd1 after activation 21 , whereas the role of CR-B remains unknown. We observed substantial transcriptional activity after activation of EL4 cells with the phorbol ester PMA and ionomycin in cells transfected with the full-length construct but not in those transfected with a version containing only the CR-B region ( Fig. 9d and Supplementary Fig. 10a ), as reported before 21 . T-bet inhibited the activity of the full-length reporter construct by ~60-70% (Fig. 9d) . A version of T-bet containing point substitutions that abrogate binding to DNA 23 had expression similar to that of wild-type T-bet but was unable to mediate repression of the reporter (Fig. 9d  and Supplementary Fig. 10) . Thus, T-bet repressed PD-1 expression A r t i c l e s by a mechanism that required DNA binding. Consistent with the data obtained with EL4 cells, P14 cells retrovirally transduced with T-bet expressed less PD-1 than did cells transduced with empty vector after 3 d of culture (Fig. 9e,f) , although the extent of PD-1 repression was less than that noted in vivo during chronic infection (Fig. 7b) . Thus, genetic ablation in vivo as well as overexpression in vitro and in vivo all demonstrated repression of PD-1 expression by T-bet.
To determine whether T-bet bound directly to regulatory elements of Pdcd1, we did chromatin-immunoprecipitation (ChIP) analysis. We did not detect specific enrichment of T-bet at Pdcd1 after ChIP in exhausted CD8 + T cells isolated from clone 13-infected mice (Fig. 9g) , although we did observe some binding to the locus encoding IFN-γ (Ifng) in these cells, probably due to a more optimal T-bet binding site in the regulatory region of Ifng. In contrast, in CD8 + T cells activated in vitro or isolated from Arm-immune mice, which all expressed less PD-1 than did exhausted CD8 + T cells, T-bet physically associated with Pdcd1 in a region ~500 base pairs upstream of the transcriptional start site, near or within the 'B' region (Fig. 9g) . We did not detect binding to the Pdcd1 regulatory region in Tbx21 −/− CD8 + T cells (Supplementary Fig. 11 ). However, we also observed binding of T-bet to Pdcd1 in T helper type 1-polarized CD4 + T cells activated in vitro (Fig. 9h) . Together these results demonstrate that T-bet acts as a repressor of PD-1 expression by directly binding to upstream regulatory elements of Pdcd1.
DISCUSSION
In this study we have demonstrated a critical role for T-bet in sustaining antiviral CD8 + T cell responses during chronic viral infection. In contrast to its effects during acute infection, during chronic infection, high T-bet expression improved the long-term durability of antigenspecific CD8 + T cells. Sustained T-bet expression repressed inhibitory receptors, whereas low expression of T-bet resulted in high expression of PD-1 and exacerbated CD8 + T cell exhaustion.
T-bet directly repressed PD-1 expression in LCMV-specific CD4 + and CD8 + T cells and bound to the regulatory region upstream of Pdcd1. An identified NFAT site critical for PD-1 expression 21 is also located upstream of Pdcd1, which suggests potential transcription factor cooperation or antagonism in PD-1 expression. Indeed, T-bet can repress NFAT-mediated transactivation in other settings 24 , but the connection between T-bet and NFAT on Pdcd1 transcription will require further analysis. In addition to a possible relationship between NFAT and T-bet, Blimp-1 and T-bet have analogous roles during acute infection whereby high expression of these two transcription factors drives CD8 + T cells to become functional, terminally differentiated effectors 14, 15 . However, these two transcription factors seem to have opposing roles during chronic infection, in which high Blimp-1 expression 12 promotes exhaustion and inhibitory receptor expression, whereas T-bet has low expression in this setting. A tightly coupled reciprocal expression pattern for T-bet and eomesodermin has also been observed 16, 17 , as well as for Blimp-1 and Bcl-6 (ref. 25) , which suggests a complex but coordinated transcriptional program. In addition, as T-bet (and Blimp-1 (ref. 12) ) also regulated expression of LAG-3 and CD160, it will be useful to further define how the constellation of key transcription factors expressed by exhausted T cells acts together to guide this developmental program.
Pdcd1 was not identified as a target of T-bet by either ChIP plus genome-wide microarray analysis 26 or ChIP followed by genomewide sequencing (unpublished observations). The binding of T-bet to Pdcd1 seemed to be weaker than its binding to other canonical targets such as Ifng, and we did not identify typical dimeric T-bet sites in the Pdcd1 region at which T-bet bound, which suggested that T-bet might interact with degenerate T-box half-sites present in this region. It is possible that this T-bet-Pdcd1 interaction was below the limit of detection of genome-wide techniques. Such a model could also explain why in exhausted CD8 + T cells in which T-bet expression is low, binding of T-bet to Pdcd1 is lost but binding to more optimal sites like Ifng is preserved. In other settings, such as in memory or in vitro-activated CD8 + T cells, in which T-bet is more abundant, there is probably sufficient T-bet protein to bind to weaker sites such as those in Pdcd1. Thus, whereas large-scale screening approaches are invaluable, alternative methods might be needed to identify other potentially important biological transcriptional targets.
The relationship between T-bet and PD-1 may differ depending on the context. For example, the inverse correlation between PD-1 and T-bet during chronic infection became apparent only after ~15 d of infection. In addition, genetic ablation of T-bet during acute infection resulted in slightly higher PD-1 expression on CD8 + T cells but on its own was insufficient to drive PD-1 expression to the extent observed during chronic infection. Therefore, persistent antigen signals or other transcription factors together with T-bet probably provide context-specific and temporal regulation of PD-1 and other inhibitory receptors. Notably, virus-specific CD8 + T cells in chronically infected cKO and cHet mice had similarly high PD-1 expression, but the defects in cKO CD8 + T cells were much more pronounced, which suggested a PD-1-independent role for residual T-bet in cHet mice. Nevertheless, T-bet is a critical transcriptional regulator of Pdcd1 and affects the expression of many inhibitory receptors, especially during later stages of chronic infection.
The distinct expression of T-bet during acute and chronic viral infection also has potential implications for understanding of the molecular relationship between terminal differentiation and exhaustion. High T-bet expression promotes terminal differentiation 15, 16 but represses certain features of exhaustion. Notably, phenotypic markers of terminal differentiation such KLRG-1 (refs. 4, 8) or CD57 do not necessarily correlate with exhaustion or PD-1 expression 27, 28 . Such observations, including the distinct roles of T-bet during acute infection versus chronic infection, support the idea that the terminal differentiation and exhaustion of CD8 + T cells follow distinct molecular paths, although further studies are warranted.
The lower T-bet expression during chronic LCMV infection than during acute LCMV infection was unexpected, given the greater antigen and inflammation associated with infection with clone 13. There is higher expression of IFN-α, IFN-β 29 and IFN-γ 30 and of interferonresponsive genes 4 during chronic LCMV infection. IFN-γ signaling reinforces T-bet expression during T helper type 1 differentiation 31 , and type I interferons can induce IFN-γ production 32 or might themselves regulate T-bet 33 . Although TCR signaling is necessary for the initiation of T-bet induction, we found that prolonged TCR stimulation led to downregulation of T-bet in the presence of persistent inflammation. One possible mechanism, given the published in vitro data and modeling work 18 as well as the in vivo studies presented here, is that persistent TCR signaling decouples the ability of inflammation to increase or sustain T-bet expression. Such observations suggest that there might be opportunities to preserve T-bet expression during chronic infection if the intracellular regulatory mechanisms can be defined.
In humans, chronic infection can also lead to T cell exhaustion and upregulation of inhibitory receptors, such as PD-1 (ref. 2) . Given the potential relationship among antigen, inflammation and T-bet, it would be useful to investigate coexpression of T-bet and PD-1 in some of these settings. During chronic infection with hepatitis C virus, therapy with pegylated type I interferon is effective in only a subset of patients, and determining whether T-bet correlates with the clinical outcome of such infection and/or interferon treatment could be informative. Although T-bet expression could be different in T cells responding to latent and/or reactivating viral infections, for infections with sustained and high viral replication, our data indicate that dysregulation of T-bet expression could underlie at least part of the defects in exhausted CD8 + T cells, including high expression of inhibitory receptors and failure to sufficiently sustain T cell immunity. Future studies that aim to increase T-bet expression could lead to therapeutic strategies to diminish T cell exhaustion and improve immunity during chronic viral infection in humans. 
METHODS
Methods
ONLINE METHODS
Mouse strains. B6 and congenic (CD45.1 + ) B6 mice were from the National Cancer Institute. Tbx21 fl mice have been described before 17 ; these mice were backcrossed to the B6 strain for at least ten generations, then were crossed with Cd4-Cre-transgenic mice to produce F 1 littermates that were intercrossed to generate mice with conditional deletion of one allele of Tbx21 (cHet) or both alleles of Tbx21 (cKO). Mice with germline knockout of T-bet (Tbx21 −/− ) 34 were crossed with P14 mice on a CD45.1 + background; the littermates were intercrossed to produce P14 mice on a mixed CD45.1 + CD45.2 + background with deletion of one or both alleles of Tbx21. Mice were used between 5 and 20 weeks of age. All mice were age matched in experiments comparing B6 mice with cHet and cKO mice. All animal work was in accordance with the Institute Animal Care and Use Guidelines for the University of Pennsylvania, University of Washington and the Wistar Institute.
Viral infection, plaque assay and in vivo antibody treatment. LCMV strains were produced and titers were measured as described 35 . Mice were infected by intraperitoneal injection of LCMV Armstrong strain (2 × 10 5 plaque-forming units) or intravenous injection of LCMV clone 13 (4 × 10 6 plaque-forming units for wild-type clone 13 and 2 × 10 6 plaque-forming units for the V35A variant). V35A clone 13 has been described 19 . For infection of mice depleted of CD4 + T cells, 200 µg antibody to CD4 (GK1.5; BioXcell) was injected twice intraperitoneally 1 d before and 1 d after infection with clone 13.
Flow cytometry, antibodies, reagents and peptide restimulation. Lymphocytes were isolated from blood, bone marrow, spleen, lymph node, brain and liver as described 36 . Biotinylated monomers of H-2D b gp33 or H-2D b gp276 were produced, refolded, biotinylated and made into tetramers through the use of streptavidin-allophycocyanin (Molecular Probes, Invitrogen) as described 36 . I-A b gp66 tetramerswere obtained from the National Institutes of Health Tetramer Core. Antibodies for flow cytometry are in Supplementary Table 1 . Surface staining with antibodies and tetramers for flow cytometry have been described 36 , and a Cytofix/Cytoperm kit was used according to the manufacturer's instructions (BD Biosciences) for intracellular cytokine staining. For intracellular staining with antibody to T-bet (4B10; Santa Cruz Biotechnology) conjugated to fluorescein isothiocyanate or Alexa Fluor 488, cells were fixed in 1% (wt/vol) formaldehyde in PBS, followed by permeabilization and staining for 1-2 h in 0.1% (vol/vol) Triton X-100 and 1% (vol/vol) FBS in PBS, then fixation again in 1% (wt/vol) formaldehyde in PBS. Lymphocytes were restimulated for 5-7 h at 37 °C in 5% CO 2 incubator with individual LCMV peptides (~200 nM) or a pool of 20 LCMV peptides 37 . An LSR II (BD ImmunoCytometry Systems) was used for flow cytometry and data were analyzed with FlowJo 9.0.1 software (Treestar).
Cell lines. The 293T human embryonic kidney cell line was provided by W. Pear. The EL4 and A20 cell lines were obtained from American Type Culture Collection.
Retroviral production, transduction, labeling with the cytosolic dye CFSE and adoptive transfer. Tbx21 cDNA was previously cloned into the MIG retrovirus 38 . Empty MIG or T-bet-expressing MIG was produced in 293T cells by the calcium-phosphate method as described 39 . Naive P14 cells were activated in vitro for 12-24 h with H-2D b gp33, then were transduced with retroviral supernatants by 'spin' infection as follows: 1 ml retroviral supernatant containing polybrene (0.8 µg/ml) mixed with ~1 × 10 6 activated P14 cells in 24-well plates was centrifuged at 1,200g for 90 min at 20 °C. P14 cells (5 × 10 3 CD8 + cells) were then immediately transferred intravenously into B6 hosts (infected 12-24 h before with Arm or clone 13). EL4 cells were transduced without preactivation. For experiments assessing early T-bet expression in antigen-specific CD8 + T cells, P14 CD8 + splenocytes were labeled with CFSE (carboxyfluorescein diacetate succinimidyl ester) as described 36 , and 1 × 10 6 labeled P14 CD8 + cells were transferred intravenously into congenic B6 hosts, which were infected with Arm or clone 13 the next day, then examined on day 1 or day 3 after infection for donor P14 cells in the spleen. For mixed P14 T-bet chimeras, equal numbers of wild-type and Tbx21 +/− or Tbx21 −/− P14 CD8 + T cells (1 × 10 3 ) were transferred together intravenously into congenic B6 hosts, which were then infected with Arm or clone 13 and analyzed. For adoptive transfer of Tbx21 fl CD4-Cre cells into B6 hosts, suspension of splenocytes containing 2 × 10 7 CD8 + T cells were transferred intravenously into each congenic B6 host, which were then infected with Arm or clone 13. For transfer experiments involving V35A clone 13, donor mice were initially infected with wild-type clone 13; at day 8 after infection, splenocyte populations from donor mice were enriched for CD8 + T cells by negative selection with DynaBeads (Invitrogen), then ~1.5 × 10 6 H-2D b gp33-specific CD8 + cells (and ~1.0 × 10 6 H-2D b gp276-specific CD8 + T cells) were transferred intravenously into congenic hosts infected 8 d before with wild-type or V35A clone 13.
Stimulation of CD4 + and CD8 + T cells, ChIP and PCR. ChIP analysis of in vitro-activated, T helper type 1-polarized wild-type or Tbx21 −/− CD4 + T cells was done as described 22 . Wild-type or Tbx21 −/− P14 splenocytes were stimulated for 5-6 d with H-2D b gp33 (50 nM) and were cultured in IL-2 (100 U/ml; National Institutes of Health). Cultures were split every 2 d with medium containing IL-2. P14 cells were restimulated for 5 h with PMA (phorbol 12-myristate 13-acetate; 50 ng/ml) and ionomycin (1 µM) before ChIP. For P14 cells, fixed cells were sonicated with a Bioruptor (Diagenode), and a ChIP assay kit was used according to the manufacturer's instructions (Millipore/Upstate) for ChIP (antibodies, Supplementary Table 1) . Rabbit polyclonal antibody to T-bet (H-210; Santa Cruz Biotechnology) or normal rabbit IgG was used for ChIP. Primers for amplification of the region upstream of Pdcd1 were as follows: −0.5 kb, 5′-GGTGTCTGGAGAGGAAA GGC-3′ (forward) and 5′-CTACCTTGTCTGCCATGCGTG-3′ (reverse); −1.5 kb, 5′-CCTTGCTCCTCACCACACTGC-3′ (forward) and 5′-CAGA GCAGATCATGAGGACTG-3′ (reverse). ChIP primers for Ifng and Hprt1 have been described 40 .
DNA constructs, EL4 restimulation and luciferase assay. Construction of the PD-1 reporter containing either ~400 base pairs (PD-1 B) or ~2,300 base pairs (full-length; PD-1 B+C) of Pdcd1 upstream regulatory elements into the pGL3Basic vector (Promega) and pEF1 (Invitrogen) with T-bet has been described 21, 29 . The T-bet DNA-binding mutant has two point substitutions of arginine residues at positions 163 and 164 as described 23 . EL4 cells were restimulated with PMA and ionomycin and transfected with the Nucleofection kit (Amaxa-Lonza) as described 22 . Dual-luciferase assays were done according to the manufacturer's instructions (Promega) and expression was normalized to expression of the renilla luciferase control vector pRL (Promega).
Statistical analysis. P values for statistical significance were calculated with a paired or unpaired two-tailed Student's t-test.
